Alvogen keeps growing! But it is not only revenue growth through external acquisitions but a very healthy balance between internal growth through registrations and product launches across the globe...

Our Senior Management team gathered in Reykjavik, Iceland, recently to hold our annual strategic kick-off  meeting, where we discussed our business goals and priorities for the year ahead. As usual, I was reminded of what a fantastic group of people we have working together at Alvogen.

An eventful year is passing. A year full of excitement and challenges. This time of year is a time of joy and peace. Time for generosity and precious moments.  Now it is time to rest and enjoy quality time with friends and family and gather our strength for the exciting times ahead.

I've just returned from Madrid, where I attended CPhI, the world's largest pharmaceutical fair. As always, it was tremendously exciting to meet so many partners and customers and to share with them our vision for the future of the generics industry.

We’re in the midst of a busy and exciting fall at Alvogen. As will participate in the  world’s largest pharmaceutical fair, CPhI in Madrid, Spain.  I’ll be there, along with 30 other members of Alvogen’s senior management.

Our playing field is the international generic industry. This is an industry with vast untapped potential, both geographically and technically, as generic pharmaceuticals become available in more markets and new difficult-to-make formulations are added to the generic portfolio. The industry is recession resistant by nature and is an answer to rising healthcare costs and ongoing need to improve the efficiency of healthcare systems around the world.